Accessibility Tools
Breaking News: Myonex appoints Greg Lavin as Chief Executive Officer as James Lovett retires, joins Board of Directors
Article
Breaking Barriers in Clinical Trial Accessibility in all US 50 States
Executive Insights
Rethinking Drug Procurement in Clinical Trials: Hedging Against Unpredictability
Case Study
A Smart Hybrid Comparator Sourcing Model for Global Oncology Trial Success
Delivering Hope through Expanded Access: Custom-Compounded Medication & Direct-To-Patient Supply
Webinar
Bridging the Gap: Direct-to-Patient Strategies to Support Diversity in Clinical Trials
Is Clinical Supply the Weakest Link in Your Chain?
Broader Cell Therapy Trial Reach Through Sterile Compounding Capabilities
When Smarter Multi-SKU Commercial Packaging Drives Long-Term Success
Overcoming Sourcing Challenges for a High-Demand Drug with a Smart Combination of Sourcing Pathways
Oncology Breakthrough with Direct-to-Patient Supply
Diabetes Innovation with CTRx™ and Direct-to-Patient Supply
A Closer Look at Myonex’s Bioservices Capabilities